Sight Sciences
(NASDAQ) SGHT
Sight Sciences Financials at a Glance
Market Cap
$289.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$79.55M
Net Income (TTM)
-$37.25M
EPS (TTM)
-$0.71
P/E Ratio
-7.54
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.33
Volume
3,412
Open
$5.41
Price
$5.33
Volume
3,412
Open
$5.41
Previous Close
$5.33
Daily Range
$5.20 - $5.41
52-Week Range
$3.11 - $9.24
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.33
Volume
3,412
Open
$5.41
Previous Close
$5.33
Daily Range
$5.20 - $5.41
52-Week Range
$3.11 - $9.24
Estimated Earnings Date
Aug 6, 2026
SGHT News
SGHT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sight Sciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
186
CEO
Paul Badawi, MBA
Website
www.sightsciences.comHeadquarters
Menlo Park, CA 94025, US
SGHT Financials
Key Financial Metrics (TTM)
Gross Margin
86.17%
Operating Margin
-44.82%
Net Income Margin
-46.83%
Return on Equity
-59.10%
Return on Capital
-35.43%
Return on Assets
-33.96%
Earnings Yield
-13.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$289.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
54.41M
Volume
3.41K
Avg. Volume
241.94K
Financials (TTM)
Gross Profit
$68.55M
Operating Income
-$35.65M
EBITDA
-$31.68M
Operating Cash Flow
-$25.12M
Capital Expenditure
-$284.00K
Free Cash Flow
-$25.40M
Cash & ST Invst.
$84.96M
Total Debt
$41.76M
Sight Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.70M
+12.5%
Gross Profit
$16.98M
+12.5%
Gross Margin
86.19%
N/A
Market Cap
$289.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.34M
N/A
Employees
216
N/A
Net Income
-$12.98M
+8.3%
EBITDA
-$11.60M
+8.7%
Quarterly Fundamentals
Total Cash
$84.96M
-21.9%
Total Debt
$41.76M
+3.2%
Accounts Receivable
$10.60M
+12.4%
Inventory
$7.01M
+20.7%
Long Term Debt
$37.61M
-5.8%
Short Term Debt
$4.16M
+652.7%
Return on Assets
-33.96%
N/A
Return on Invested Capital
-38.95%
N/A
Free Cash Flow
-$7.09M
+38.9%
Operating Cash Flow
-$7.03M
+39.4%